Role in inflammation in the pathogenesis of unstable coronary artery diseases

Scandinavian Journal of Clinical and Laboratory Investigation, Supplement

Volumn 59, Issue 230, 1999, Pages 12-22

  Biasucci, Luigi M ^a   Colizzi, Christian ^a   Rizzello, Vittoria ^a   Vitrella, Giancarlo ^a   Crea, Filippo ^a   Liuzzo, Giovanna ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ATHEROSCLEROTIC PLAQUE; CELL ACTIVATION; CONFERENCE PAPER; CORONARY ARTERY DISEASE; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; PATHOGENESIS; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; THROMBOGENESIS; UNSTABLE ANGINA PECTORIS; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY BLOOD VESSEL; HEART INFARCTION; IMMUNOLOGY; REVIEW;

ANGINA, UNSTABLE; CORONARY ARTERIOSCLEROSIS; CORONARY VESSELS; HUMANS; INFLAMMATION; MYOCARDIAL INFARCTION;

EID: 0032617572     PISSN: 0085591X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (64)

1. Vejar M, Hackett D, Brunelli C, Spallarossa P, Lanetta M, Galassi AR, Lipkin D, Caponnetto S, Patrono C, Maseri A. Comparison of low-dose aspirin and coronary vasodilators in acute unstable angina. Circulation 1990; 81 (suppl I):I4-I11.
2. Gold HK, Johns JA, Lemback RC, Yasuda T, Grosbard E, Zusman R, Colien D. A randomized, blinded placebo-controlled trial of recombinant human tissue-type plasminogen activator in patients with unstable angina pectoris. Circulation 1987; 75: 1192-1199.
3. Williams DO, Topol EJ, Califf RM, Roberts R, Mancini J, Joelson JM, Ellis SG, Kleiman NS, and co-investigators. Intravenous recombinant tissue-plasminogen activator in patients with unstable angina pectoris: results of a placebocontrolled, randomized trial. Circulation 1990; 82: 376-383.
4. Ambrose JA, Winters SL, Stern A, Eng A, Teicholz AE, Gorlin R, Fuster V. Angiographic morphology and the pathogenesis of unstable angina pectoris. J Am Coll Cardiol 1985; 5: 609-616.
5. Wilson RF, Holida MD, White CW. Quantitative angiographic morphology of coronary stenoses leading to myocardial infarction or unstable angina. Circulation 1986; 73: 286-293.
6. Forrester JS, Litvack F, Grundfest W, Hickey A. A perspective of coronary disease seen through the arteries of living man. Circulation 1987; 75: 505-513.
7. Balcon R, Brooks N, Warnes C, Cattell M. Clinical spectrum of unstable angina. In: Rafflenbeul W, Lichtlen PR, Balcon R, eds. Unstable Angina Pectoris. International Symposium, Hannover 1980. New York: Thieme-Stratton, 1981: 42-4.
8. Moise A, Thereoux P, Taeymans Y, Descoings B, Lesperance J, Waters DD, Pelletier GB, Bourassa MG. Unstable angina and progression of coronary atherosclerosis. N Engl J Med 1983; 309: 685-689.
9. Neill WA, Wharton TP Jr, Fluri-Lundeed J, Cohen IS. Acute coronary insufficiency-coronary occlusion after intermittent ischemic attacks. N Engl J Med 1980; 302: 1157-1162.
10. Falk E. Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis. Characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi. Br Heart J 1983; 50: 127-134.
11. Davies M, Thomas A. Thrombosis and acute coronary artery lesions in sudden cardiac ischemie death. N Engl J Med 1984; 310: 1137-1140.
12. Kohchi R, Takebayashi S, Hiroki T, Nobuyoshi M. Significance of adventitial inflammation of the coronary artery in patients with unstable angina. Results at autopsy. Circulation 1985; 71: 709-716.
13. Wallsh E, Weinstein GS, Franzone A et al. Inflammation of the coronary arteries in patients with unstable angina. Tex Heart Inst J 1986; 16: 105-113.
14. Sato T. Increased subendothelial infiltration of the coronary arteries with monocytes-macrophages in patients with unstable angina; histological data on 14 autopsy patients. Atherosclerosis 1987; 68: 91-197.
15. Baroldi G, Silver MD, Mariani F, Giuliano G. Correlation of morphological variable in the coronary atherosclerotic plaque with clinical patterns of ischemic heart disease. Am J Cardiovasc Pathol 1988; 2: 159-172.
16. Hansson GK, Holm J, Jonasson L. Detection of activated T lymphocytes in the human atherosclerotic plaque. Am J Pathol 1989; 135: 169-175.
17. Kragel AH, Reddy SG, Wittes JT, Roberts WC. Morphometric analysis of the composition of coronary arterial plaques in isolated unstable angina pectoris with pain at rest. Am J Cardiol 1990; 66: 562-567.
18. van der Wal AC, Becker AE, van der Loos CM, Das PK. Site of intimai rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994; 89: 36-44.
19. Kaartinen M, Penttilä A, Kovanen PT. Accumulation of activated mast cells in the shoulder region of human coronary atheroma, the predilection site of atheromatous rupture. Circulation 1994; 90: 1669-1678.
20. Kovanen PT, Kaartinen M, Paavonen T. Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. Circulation 1995; 92: 1084-1088.
21. Moreno PR, Falk E, Palacios IF, Newell JB, Fuster V, Fallon JT. Macrophage infiltration in acute coronary syndromes: implications for plaque rupture. Circulation 1994; 90: 775-778.
22. van der Wal AC, Das PK, van de Berg DB et al. Atherosclerotic lesions in humans - In Situ Immunophenotypic analysis suggesting an immune mediated response. Lab Invest 1989; 61: 166-170.
23. Arbustini E, Grasso M, Diegoli M et al. Coronary atherosclerotic plaques with and without thrombus in ischemic heart syndromes: a morphologic immunohistochemical and biochemical study. Am J Cardiol 1991; 68: 36B-50B.
24. Di Sciascio G, Cowley MJ, Gondreau E et al. Histopathologic correlates of unstable ischemic syndromes in patients undergoing directional coronary atherectomy: in vivo evidence of thrombosis, ulceration, and inflammation. Am Heart J 1994; 128: 419-426.
25. Henney AM, Wakeley PR, Davies MJ et al. Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc Natl Acad Sci USA 1991; 88: 8154-8158.
26. Shah PK, Falk E, Badimon JJ et al. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implication for plaque rupture. Circulation 1995; 92: 1565-1569.
27. Wilcoxon JN, Smith KM, Schwartz SM, Gordon D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci USA 1989; 86: 2839-2843.
28. Leatham EW, Bath PMW, Tooze JA, Camm AJ. Increased monocyte tissue factor expression in coronary disease. Br Heart J. 1995; 73: 10-13.
29. Linnanmäki E, Leinonen M, Manila K et al. Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary heart disease. Circulation 1993; 87: 1130-1134.
30. Kuo C-C, Shor A, Campbell LA et al. Demonstration of Chlamydia pneumoniae in atherosclerotic lesion of coronary arteries. J Infect Dis 1993; 167: 841-849.
31. Kol A., Sukhova G.K., Lichtman A.H., Libby P. Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage Tumor Necrosis Factor-α and Matrix Metalloproteinase expression. Circulation 1998, 98: 300-307.
32. Wallsh E, Weinstein GS, Franzone A, Clavel A, Rossi PA, Kreps E. Inflammation of the coronary arteries in patients with unstable angina. Tex Hearth Inst J 1986, 16: 105-13.
33. Mazzone A, De Servi S, Ricevuti G et al. Increased expression of neutrophil and monocyte adhesion molecules in unstable coronary artery disease. Circulation 1993; 88: 358-363.
34. Vejar M, Fragasso G, Hackett D et al. Dissociation of platelet activation and spontaneous myocardial ischemia in unstable angina. Thromb & Haemostas 1990; 63: 163-168.
35. Neri Serneri GG, Gensini GF, Modesti PA et al. The role of extraplatelet thromboxane A2 in unstable angina investigated with a dual thromboxane A2 inhibitor: importance of activated monocytes. Coron Artery Dis 1994; 5: 137-145.
36. Carry M, Korley V, Willerson JT et al. Increased urinary leukotriene excretion in patients with cardiac ischemia: in vivo evidence for 5-lipoxygenase activation. Circulation 1992; 85: 230-236.
37. Mehta J, Dinerman J, Mehta P et al. Neutrophil function in ischemic heart disease. Circulation 1989; 79: 549-556.
38. Dinerman JL, Mehta JL, Saldeen TGP et al. Increased neutrophil elastase release in unstable angina pectoris and acute myocardial infarction. J Am Coll Cardiol 1990; 15: 1559-1563.
39. Biasucci LM, D'Onofrio G, Liuzzo G et al. Intracellular neutrophil myeloperoxidase is reduced in unstable angina and myocardial infarction, but its reduction is not related to ischemia. J Am Coll Cardiol 1996; 27; 3: 611-616.
40. Neumann FJ, Katus HA, Hoberg E et al. Increased plasma viscosity and erythrocyte aggregation: indicators of an unfavourable clinical outcome in patients with unstable angina. Br Heart J 1991; 66: 425-430.
41. Neri Serneri GG, Abbate R, Gori AM et al. Transient intermittent lymphocyte activation is responsible for the instability of angina. Circulation 1992; 86: 790-797.
42. Liuzzo G, Kopecky SL, Goronzy JJ et al. Disease specific patients of cytokine production by T-lymphocytes in coronary atherosclerosis: evidence for a role of infectious agents in the pathogenesis of unstable angina? J Am Coll Cardiol 1998, 31; s2: 187A. (Abstract)
43. Berk B C, Weinbraub W S, Alexander RW. Elevation of C-reactive protein in active coronary disease. Am J Cardiol 1990; 65: 168-172.
44. Liuzzo G, Biasucci LM, Gallimore JR et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. New Engl J Med 1994; 331: 417-424.
45. Biasucci LM, Liuzzo G, Fantuzzi G, Caligiuri G, Rebuzzi AG, Ginnetti F, Dinarello CA, Maseri A. Increasing levels of IL-1Ra and of IL-6 during the first two days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events. Circulation 1999, in press.
46. Haverkate F, Thompson SG, Pyke SDM et al. Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet 1997, 349: 462-6.
47. Ridker PM, Cushman M, Stampfer MJ et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. New Engl J Med 1997, 336: 973-9.
48. Liuzzo G, Biasucci LM, Rebuzzi AG et al. The plasma protein acute phase response in unstable angina is not induced by ischemic injury. Circulation 1996; 94: 2373-2380.
49. Liuzzo G, Buffon A, Biasucci LM et al. Enhanced inflammatory response to coronary angioplasty in patients with severe unstable angina. Circulation 1998; 98: 2370-2376.
50. Biasucci LM, Liuzzo G, Caligiuri G et al. Activation of the coagulation system doesn't elicit a detectable acute phase reaction in unstable angina. Am J Cardiol 1996; 77: 85-87.
51. Biasucci LM, Liuzzo G, Grillo RL et al. Elevated levels of C-Reactive protein at discharge in patients with unstable angina predict recurrent instability. Circulation 1999, in press.
52. Liuzzo G, Angiolillo DJ, Ginnetti F, Caligiuri G, Rizzello V, Petrone E, Kol A, Sperti G, Biasucci LM; Maseri A. Monocytes of patients with recurrent unstable angina are hyper-responsive to lypopolysaccaride challenge. J. Am. Coll. Cardiol. 1998; 31; s2: 272A (Abstract).
53. Versaci F, Tomai F, Gaspardone A et al. Assessment of C-reactive protein levels after percutaneous transluminal coronary angioplasty and stent implantation. Eur Heart J 1996; 17: 256.
54. Bevilacqua MP, Gimbrone MA. Inducible endothelial functions in inflammation and coagulation. Sem Thromb Hemost 1987; 13: 425-433.
55. Collins T. Endothelial nuclear factor-kB and the initiation of the atherosclerotic lesion. Lab Invest 1993; 68: 499-508.
56. Lenardo M, Baltimore D. NF-kB: a pleiotropic mediator of inducible and tissue specific gene control. Cell 1988; 58: 227-229.
57. Peng J, Friese P, George J, Dale G, Burstem SA. Alteration of platelet function mediated by interleukin-6. Blood 1994; 83: 398-403.
58. Libby P Molecular bases of the acute coronary syndromes. Circulation 1995; 91: 2844-2850.
59. Zeiher AM, Goebel H, Schachinger V, Ihling C. Tissue endothelin-1 immunoreactivity in the active coronary atherosclerotic plaque. A clue to the mechanism of increased vasoreactivity of the culprit lesion in unstable angina. Circulation 1995; 91: 941-947.
60. Bertrand M, Lablanche LM, Tilmant P et al. Frequency of provoked coronary arterial spasm in 1089 consecutive patients undergoing coronary arteriography. Circulation 1982; 65: 1299-1306.
61. Bogaty P, Hacken D, Davies G, Maseri A. Vasoreactivity of the culprit lesion in unstable angina. Circulation. 1994; 90: 5-11.
62. Yang Z, Richard D, Von Segesser L et al. Threshold concentrations of endothelin-1 potentiate contractions to norepinephrine and serototnin in human arteries: a new mechanism of vasospasm. Circulation 1990; 82: 188-195.
63. Shimokawa H, Ito A, Fukumoto Y, Kadokami T et al. Chronic treatment with interleukin-1β induces coronary intimal lesions and vasospastic responses in pigs in vivo. J Clin Inv 1996; 97: 769-776.
64. Liuzzo G, Buffon A, Vitelli A et al. Plasma levels of interleukin-6 predict restenosis following coronary angioplasty in patients with unstable angina. Circulation 1996; 94: I-330.